Liver Disease
News
Threefold increase in cirrhosis risk with HCV
Key clinical point: Individuals with hepatitis C infection are three times more likely to develop cirrhosis than are those who are hepatitis C...
From the AGA Journals
Human liver cells can induce antiviral reaction against hepatitis C
Key clinical point: Cultured primary human liver sinusoidal endothelial cells (HLSECs) induce self-amplifying interferon-mediated responses and...
News
HCV continuum critical to providing better care in urban areas
Key clinical point: Education regarding appropriate hepatitis testing, referral, support, and care is critical to mitigating loss of patients at...
News
Updated HIV, HCV, HBV blood product screening test approved
News
Aetna customers to receive discount on Gilead’s hepatitis C treatment
Conference Coverage
Transsplenic TIPS procedure catching on for portal vein thrombosis
News
Analysis: Push for expanded hepatitis C screening appears premature
Key clinical point: Evidence to support expanded hepatitis C screening is lacking. Major finding: An estimated 80%-85% of patients with chronic...
Conference Coverage
Best HCV value? Screen all baby boomers, treat all infections
Key clinical point: Screening adults born in 1945-1965 and treating all who have HCV with oral anti-HCV regimens is most cost effective. Major...
From the AGA Journals
Sofosbuvir and ribavirin critical to preventing posttransplantation HCV recurrence
News
Diet, exercise reduced portal hypertension in obese cirrhotic patients
Key clinical point: A 16-week lifestyle intervention safely reduced body weight and portal pressure in obese patients with cirrhosis. Major...